Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Grillo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
ACS Medicinal Chemistry Letters|December 20, 2023
Development of Allosteric NIK Ligands from Fragment-Based NMR ScreeningJared J Anderson, Michael J Grillo, Daniel A Harki
Trends in Pharmacological Sciences|March 11, 2022
The current toolbox for APOBEC drug discoveryMichael J Grillo, Katherine F M Jones, Michael A Carpenter, et al.
ACS Chemical Biology|October 22, 2025
Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine DeaminaseRamkumar Moorthy, Michael J Grillo, Jordan W Baur, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Development of Allosteric Small Molecule APOBEC3B Inhibitors from <i>In Silico</i> ScreeningKatherine F M Jones, Özlem Demir, Mackenzie K Wyllie, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Fragment-Based NMR Screening of the BPTF PHD Finger Methyl Lysine Reader Leads to the First Small-Molecule InhibitorsCaroline R Buchholz, Molly S Sneddon, Joseph E McPherson, et al.
ACS Chemical Biology|December 16, 2024
The Impact of Sugar Conformation on the Single-Stranded DNA Selectivity of APOBEC3A and APOBEC3B EnzymesMackenzie K Wyllie, Clare K Morris, Nicholas H Moeller, et al.
Cell Chemical Biology|January 8, 2025
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degradersJian Tang, Ramkumar Moorthy, Laura E Hirsch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|December 20, 2023
Development of Allosteric NIK Ligands from Fragment-Based NMR ScreeningJared J Anderson, Michael J Grillo, Daniel A Harki
Trends in Pharmacological Sciences|March 11, 2022
The current toolbox for APOBEC drug discoveryMichael J Grillo, Katherine F M Jones, Michael A Carpenter, et al.
ACS Chemical Biology|October 22, 2025
Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine DeaminaseRamkumar Moorthy, Michael J Grillo, Jordan W Baur, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Development of Allosteric Small Molecule APOBEC3B Inhibitors from <i>In Silico</i> ScreeningKatherine F M Jones, Özlem Demir, Mackenzie K Wyllie, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Fragment-Based NMR Screening of the BPTF PHD Finger Methyl Lysine Reader Leads to the First Small-Molecule InhibitorsCaroline R Buchholz, Molly S Sneddon, Joseph E McPherson, et al.
ACS Chemical Biology|December 16, 2024
The Impact of Sugar Conformation on the Single-Stranded DNA Selectivity of APOBEC3A and APOBEC3B EnzymesMackenzie K Wyllie, Clare K Morris, Nicholas H Moeller, et al.
Cell Chemical Biology|January 8, 2025
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degradersJian Tang, Ramkumar Moorthy, Laura E Hirsch, et al.
Pageof 1